Endo International plc - Ordinary Shares (ENDP): Price and Financial Metrics


Endo International plc - Ordinary Shares (ENDP)

Today's Latest Price: $3.39 USD

0.15 (-4.24%)

Updated Aug 7 12:00am

Add ENDP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ENDP Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for ENDP is -4.2 -- better than merely 3.04% of US stocks.
  • ENDP's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 1.74% of US stocks.
  • Over the past twelve months, ENDP has reported earnings growth of -736.44%, putting it ahead of just 2.77% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Endo International plc are SIX, SGMS, NCMI, TLGT, and EGLE.
  • Visit ENDP's SEC page to see the company's official filings. To visit the company's web site, go to www.endo.com.
ENDP Daily Price Range
ENDP 52-Week Price Range

ENDP Stock Price Chart Technical Analysis Charts


ENDP Price/Volume Stats

Current price $3.39 52-week high $7.10
Prev. close $3.54 52-week low $1.97
Day low $3.34 Volume 4,621,900
Day high $3.55 Avg. volume 6,077,358
50-day MA $3.57 Dividend yield N/A
200-day MA $4.35 Market Cap 778.70M

Endo International plc - Ordinary Shares (ENDP) Company Bio


Endo International plc focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The company was founded in 1920 and is based in Dublin, Ireland.

ENDP Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$3.39$2.08 -42%

We started the process of determining a valid price forecast for Endo International plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Endo International plc ranked in the 35th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Endo International plc, consider:

  • 9% of the company's capital comes from equity, which is greater than merely 3.46% of stocks in our cash flow based forecasting set.
  • Endo International plc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
  • The weighted average cost of capital for the company is 17. This value is greater than 97.99% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-44%
1%-43%
2%-42%
3%-42%
4%-41%
5%-41%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ENDP, try GSK, STAA, USPH, ENTA, and MD.





ENDP Latest News Stream


Event/Time News Detail
Loading, please wait...

ENDP Latest Social Stream


Loading social stream, please wait...

View Full ENDP Social Stream

Latest ENDP News From Around the Web

Below are the latest news stories about Endo International plc that investors may wish to consider to help them evaluate ENDP as an investment opportunity.

Endo Announces Second Quarter 2020 Earnings Call Time Change

Endo International plc (NASDAQ: ENDP) today announced that it has changed the time of its previously announced conference call in an attempt to reduce conflicts with other earnings calls. The Company will now host a conference call and webcast on second-quarter 2020 financial results on August 6, 2020 at 7:00am EDT before the U.S. financial markets open. A press release with second-quarter 2020 financial results will be issued after the market closes on August 5, 2020.

Yahoo | July 30, 2020

CLASS ACTION UPDATE for ENDP, FE and VEL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / July 30, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.

Yahoo | July 30, 2020

Endo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Endo International plc To Contact The Firm

New York, New York--(Newsfile Corp. - July 30, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Endo International plc ("Endo" or the "Company")(NASDAQ:ENDP) of the August 18, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.If you invested in Endo stock or options between August 8, 2017 and June 10, 2020 and would like ...

Yahoo | July 30, 2020

Earnings Preview: Endo International (ENDP) Q2 Earnings Expected to Decline

Endo (ENDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 30, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FSCT, ENDP and BKD

NEW YORK, NY / ACCESSWIRE / July 29, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies.

Yahoo | July 30, 2020

Read More 'ENDP' Stories Here

ENDP Price Returns

1-mo -1.45%
3-mo -17.72%
6-mo -46.02%
1-year 38.93%
3-year -55.10%
5-year -95.94%
YTD -27.72%
2019 -35.75%
2018 -5.81%
2017 -52.94%
2016 -73.10%
2015 -15.11%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9676 seconds.